What are the fundraising trends in the AgriTech market?
In our AgriTech market deck, you will find everything you need to understand the market
SUMMARY
We analyzed publicly disclosed equity rounds raised by pure-play AgriTech companies between January 2024 and July 2026. The research only keeps disclosed equity rounds of $300K or more, and only includes companies where more than 80% of the business is tied to agricultural production, on-farm technology, agricultural inputs, or animal production technologies.
The AgriTech market remains active, but the capital environment has become more selective. Full-year funding declined from about $1.02B in 2024 to about $853M in 2025, even as deal count rose from 32 to 41.
So far in 2026, the AgriTech market has produced about $434M across 27 disclosed deals. That is slightly above the comparable period in 2025 by headline dollars, but the increase is heavily distorted by Halter’s $220M round.
The ordinary financing environment is weaker than the headline suggests. Median round size fell from $16.8M in 2024 to $10M in 2025 and $7M so far in 2026, which means the typical funded company is raising smaller checks.
Capital in the AgriTech market is increasingly winner-takes-most. In YTD 2026, the largest round captured 50.7% of all disclosed capital, the top three deals captured 68.5%, and the bottom half of deals captured only 8.3%.
Animal Health Technologies dominates YTD 2026 capital, with 67.5% of funding from only 14.8% of deals. That category’s leadership is mainly a scale-capital story driven by livestock productivity, virtual fencing, feed, and animal monitoring platforms.
Agricultural Biologicals dominate YTD 2026 deal formation, with 48.1% of all disclosed deals but only 17.6% of capital. Investors are funding many biology experiments, but most have not yet reached scale-round levels.
Farm Automation Systems remains structurally important. It led 2025 with 41.5% of deals and 39.7% of capital, but so far in 2026 its share has shifted toward smaller deployment and validation rounds.
Europe is gaining the most momentum by deal count, rising from 15.6% of deals in 2024 to 39.0% in 2025 and 63.0% so far in 2026. North America still dominates dollars, with 59.3% of YTD 2026 capital.
The practical interpretation is that the AgriTech market is not collapsing, but it is becoming much more evidence-driven. Investors are backing many early-stage biologicals, robotics, sensing, and livestock technologies, while reserving large checks for companies with deployment proof, strategic relevance, and direct farm-level ROI.
This chart, featured in our AgriTech market deck, shows revenue breakdown by customer segment in the AgriTech market
Is more or less capital going into the AgriTech market?
Less capital is going into the AgriTech market on the cleanest full-year comparison, but the freshest year-to-date signal looks artificially stronger because of one very large Halter round. Full-year disclosed equity funding fell from about $1.02B in 2024 to about $853M in 2025, a decline of roughly 16%.
That decline matters because it happened even though deal count increased from 32 deals in 2024 to 41 deals in 2025. The AgriTech market did not lose activity; it lost check size. More companies raised money, but they raised smaller rounds.
So far in 2026, disclosed AgriTech funding is about $434M versus about $414M over the comparable period in 2025. On the surface, that looks like a modest rebound. The better interpretation is more cautious because Halter’s $220M round alone represents about 51% of all YTD 2026 capital.
Excluding the largest deal from each period gives a cleaner read of the ordinary market. YTD 2026 funding excluding Halter is about $214M, while the comparable 2025 period excluding its largest round was about $270M. That means the typical financing environment is softer than the headline total suggests.
The practical takeaway is that the AgriTech market is still fundable, but not broadly easier. Investors are still writing large checks for proven platforms, especially in livestock and animal technology, while the rest of the market is operating in a more selective and smaller-round environment.
Is AgriTech funding driven by more deals or larger rounds?
AgriTech funding is being driven by more deals, not by larger typical rounds. Full-year deal count increased from 32 deals in 2024 to 41 deals in 2025, but total capital fell from about $1.02B to about $853M, average round size dropped from about $31.8M to $20.8M, and median round size fell from $16.8M to $10M.
That combination is important because it says the AgriTech market broadened by company count while weakening by check size. Investors did not stop funding the category, but they became more disciplined about how much capital they put behind each company.
The 2026 year-to-date comparison reinforces the same pattern. So far in 2026, there are 27 disclosed deals versus 17 over the comparable period in 2025, but the median round size fell from about $8.2M to $7M, and the average round size fell from about $24.3M to $16.1M despite the Halter outlier.
The round-size distribution also shows why deal count is the stronger driver. YTD 2026 has 25 of 27 deals below $20M, no deals between $20M and $50M, and only two deals above $50M. That is a market with many validation rounds and very few scale rounds.
For deeper benchmarks on how deal count, median round size, and capital concentration are shifting across the AgriTech market, see the full AgriTech market report.
Is AgriTech capital moving toward later-stage or earlier-stage companies?
AgriTech capital is still moving mainly toward later-stage companies, but deal formation is moving earlier in 2026. Full-year 2025 late-stage Series B+ and growth rounds captured about 76% of capital, compared with about 82% in 2024, so late-stage dominance softened slightly but remained overwhelming.
The 2026 year-to-date picture is more split. Seed rounds account for 17 of 27 deals, or about 63% of disclosed deals, which is a major early-stage signal. But Seed rounds account for only about $90M, or 20.7% of total capital.
By contrast, one Series D+ round, Halter’s $220M financing, represents 50.7% of all YTD 2026 capital. That means the AgriTech market is early-stage by count and late-stage by dollars.
The comparison to the same period in 2025 makes the shift clearer. Over the comparable 2025 period, Seed rounds were only 4 of 17 deals, or about 24% of deal count. So far in 2026, Seed rounds are 17 of 27 deals, which suggests early-stage experimentation has become much more visible.
The right interpretation is that investors are exploring new AgriTech companies again, but they are not giving those new companies most of the money. Scale capital still goes to companies that already have stronger commercial proof, repeat customers, or platform-level validation.
This chart, featured in our AgriTech market deck, compares the main business model options for precision agriculture platforms
Is the AgriTech market maturing or still experimental?
The AgriTech market is maturing in where the money goes, but it is still experimental in where company formation is happening. The strongest evidence is the split between 2026 deal count and capital: Seed rounds make up nearly 63% of deals, while one Series D+ deal accounts for more than half of all capital.
Full-year 2025 also looked mature by capital allocation. Series B+ and growth rounds captured about 76% of funding, while first financings represented only 17.1% of deals and 3.9% of capital. That is not an experimental capital stack; it is a validation-first capital stack.
At the same time, the AgriTech market is not mature in the sense of being dominated only by a few late-stage incumbents. YTD 2026 includes many Seed deals in Agricultural Biologicals, Farm Automation Systems, Farm Sensing Platforms, Precision Agriculture Tools, and Animal Health Technologies.
The most accurate description is a two-layer market. The top capital layer is mature and proof-driven, while the company-formation layer is still highly experimental, especially in crop biology, gene editing, RNAi, fungal biocontrol, robotics, soil sensing, and livestock intelligence.
The practical reading rule is simple: use deal count to understand experimentation, but use capital share to understand maturity. In AgriTech, those two signals point in different directions.
Are new startups still entering the AgriTech market?
Yes, new startups are still entering the AgriTech market, and the freshest evidence suggests new-company formation has become more visible in 2026. First financings accounted for 37.0% of YTD 2026 deals, up from 23.5% over the comparable period in 2025 and 17.1% for full-year 2025.
The increase is real by deal count. YTD 2026 includes first financings across crop biology, field robotics, precision tools, plant sensing, and livestock technology. That shows investors are still willing to test new AgriTech approaches rather than only recycling capital into known companies.
But new startup formation is not the same as new startup scale. First financings represent 37.0% of YTD 2026 deals but only 9.4% of capital. Investors are allowing more new companies into the market, but they are keeping initial exposure limited.
The full-year comparison adds context. In 2024, first financings were 18.8% of deals and 2.8% of capital. In 2025, they were 17.1% of deals and 3.9% of capital. So the long-run pattern is that new entrants get funded, but follow-on companies take almost all meaningful capital.
For a broader view of first financings, new entrants, and which AgriTech categories are producing new company formation, see the AgriTech market deck.
Are more investors entering the AgriTech market?
More investors appear to be participating in the AgriTech market in 2026, but the evidence points to broader participation rather than a clean surge in high-conviction specialist capital. The number of disclosed investors was approximately 100 in 2024, about 83 in 2025, and already about 99 so far in 2026.
The full-year 2025 comparison did not show investor expansion. Disclosed investor count fell from about 100 in 2024 to about 83 in 2025, while unique tier-1 investors fell from about 43 to 23. That suggests the 2025 AgriTech market became less institutionally broad even though deal count increased.
The 2026 year-to-date picture looks stronger. With 99 disclosed investors already across 27 deals, 2026 has nearly matched full-year 2024 and exceeded full-year 2025 by investor count. That is a meaningful sign that more investors are willing to look at AgriTech again.
However, participation is not the same as conviction. Many 2026 investors appear in smaller Seed rounds, while the biggest capital pools remain concentrated in a few follow-on companies. The better interpretation is that investor breadth is rebounding, but capital conviction remains selective.
The most useful investor signal is not raw investor count. In the AgriTech market, specialist and strategic investors such as Corteva Catalyst, Kubota, Capagro, AgFunder, Pymwymic, PINC, and sector-focused funds matter more than a long tail of one-time financial backers.
This chart, featured in our AgriTech market deck, illustrates yearly funding for AgriTech startups
Are top investors getting more or less active in the AgriTech market?
Top investors are not becoming uniformly more active in the AgriTech market; repeat activity is present, but it is fragmented across many specialists rather than concentrated in a few dominant funds. In 2024, S2G Ventures and Corteva/Corteva Catalyst each appeared in three deals, while Rabo/Rabobank, Orbia, Syngenta, AgFunder, and Leaps by Bayer each appeared twice.
In 2025, repeat activity was thinner. Acre Venture Partners, Pymwymic, AgFunder, and Corteva/Corteva Catalyst were the main repeat names, and the number of unique tier-1 investors fell from about 43 in 2024 to 23 in 2025.
So far in 2026, repeat investor activity has become broader again, but mostly around smaller and specialist rounds. PINC appears in three deals, while AIF, Capagro, Corteva Catalyst, Entrepreneurs First, Oyster Bay Venture Capital, Pymwymic, Simon Capital, and Unicorn India Ventures each appear twice.
The key point is that top-investor activity is changing shape. The AgriTech market does not have one obvious lead investor group setting the whole category’s pace. Instead, it has a set of domain-specialist and strategic investors showing up around specific technical areas.
That makes investor interpretation more granular. A Corteva Catalyst deal in crop biology, a Kubota deal in robotics, or a Capagro deal in farm-gate systems should carry more signal than generic VC participation because those investors can validate technical relevance, distribution channels, and farm-market fit.
Which AgriTech subcategories are gaining momentum?
Animal Health Technologies and Agricultural Biologicals are gaining the most meaningful momentum in the AgriTech market, but in different ways. Animal Health Technologies is gaining momentum by capital intensity, while Agricultural Biologicals is gaining momentum by company formation and deal count.
Animal Health Technologies captured 26.1% of full-year 2024 capital, 20.1% of full-year 2025 capital, and 67.5% of YTD 2026 capital. The 2026 share is heavily influenced by Halter’s $220M round and Innovafeed’s $59.7M round, but the direction is clear: livestock productivity, animal monitoring, virtual fencing, feed, and methane-reduction technologies are attracting large checks when they show scale proof.
Agricultural Biologicals show momentum by breadth. The category represented 25.0% of 2024 deals, 29.3% of 2025 deals, and 48.1% of YTD 2026 deals. Even though its 2026 capital share is only 17.6%, the category is producing a large pipeline of funded experiments.
Farm Automation Systems remains important but has shifted from broad 2025 leadership to more disciplined 2026 deployment funding. Automation had 41.5% of 2025 deals and 39.7% of capital, but so far in 2026 it has 18.5% of deals and 8.3% of capital.
The strongest conclusion is that investor attention is moving toward technologies that change farm economics directly: animal productivity, biological inputs, robotics, sensing, precision spraying, and input reduction. For deeper category-level context, see the deeper analysis of the AgriTech market.
Which AgriTech subcategories are losing momentum?
Farm Management Software is losing the most visible momentum in the AgriTech market. The category represented 7.7% of 2024 capital, only 1.0% of 2025 capital, and 0.0% of YTD 2026 capital.
The deal-count trend is just as clear. Farm Management Software fell from five deals in 2024 to one deal in 2025 and zero deals so far in 2026. That is a sharp decline for a category that used to sit at the center of digital agriculture narratives.
The likely reason is not that data or software stopped mattering. The stronger reading is that standalone farm SaaS is less compelling unless it is tied to sensors, agronomy workflows, hardware, sustainability infrastructure, or measurable input savings.
Precision Agriculture Tools also remain underweighted. The category had 3.5% of 2024 capital, 2.6% of 2025 capital, and 1.6% of YTD 2026 capital. Precision Ag is still investable when tied to specific input reduction or crop-monitoring use cases, but broad analytics alone is not attracting scale capital.
Farm Sensing Platforms are not collapsing, but they are not leading either. The category had 12.5% of 2024 deals but only 3.4% of capital, and so far in 2026 it has 11.1% of deals and 5.0% of capital. Sensing remains useful, but it is being valued more as an enabling layer than as the main investment thesis.
This chart, featured in our AgriTech market deck, shows why Corteva is leading in AgriTech
Which regions are gaining momentum in AgriTech funding?
Europe is gaining the most momentum in AgriTech funding by deal count, while North America remains the strongest region by capital. Europe accounted for 15.6% of deals in 2024, 39.0% of deals in 2025, and 63.0% of deals so far in 2026.
Europe’s capital share has also improved, rising from 12.3% in 2024 to 29.2% in 2025 and 38.0% so far in 2026. That is a meaningful increase, especially because European activity is spread across biologicals, robotics, precision tools, sensing, and animal technologies.
However, Europe’s momentum should be read as breadth more than scale dominance. In full-year 2025, Europe’s median round was about $7.35M, compared with $20M in North America. So Europe is producing many funded companies, but North America still produces larger financing outcomes.
North America remains the capital leader. It captured 53.9% of 2024 capital, 46.0% of 2025 capital, and 59.3% of YTD 2026 capital. The 2026 figure is heavily influenced by Halter, but North America also remains visible across biologicals, sensing, robotics, and animal technology.
The practical takeaway is that Europe is the region gaining most by startup formation, while North America remains the region gaining or retaining most by scale capital.
Which regions are losing momentum in AgriTech funding?
Asia-Pacific is losing momentum on the freshest capital comparison, but the decline needs to be interpreted carefully because earlier regional strength was heavily outlier-driven. Asia-Pacific captured 24.8% of full-year 2024 capital, 20.6% of full-year 2025 capital, and only 1.0% of YTD 2026 capital.
The apparent drop is large, but Asia-Pacific’s earlier funding totals were boosted by a few major rounds, including Scigene in 2024 and Halter in 2025. In both 2024 and 2025, Asia-Pacific’s median regional round was only about $6M, which means the region’s capital share looked more mature than the underlying deal base.
The Middle East also looks weaker than it did in 2024. The region had 9.1% of 2024 capital from companies such as Bluewhite, Greeneye, SeeTree, and Iyris, but only 1.2% of 2025 capital and 1.7% of YTD 2026 capital.
Latin America and Africa remain thin in the strict disclosed equity data. Latin America had no qualifying 2024 capital, 2.0% of 2025 capital, and none so far in 2026. Africa had no qualifying 2024 capital, 1.1% of 2025 capital, and none so far in 2026.
That does not mean those regions lack agricultural need or innovation. It means pure-play, disclosed equity rounds above $300K are sparse in authoritative public sources, and other forms of capital such as grants, development finance, revenue-based financing, or undisclosed local rounds may be more important there.
Is the AgriTech market becoming more global or more regionally concentrated?
The AgriTech market is becoming more global by deal presence, but capital remains regionally concentrated. Full-year 2025 had qualifying deals in North America, Europe, Asia-Pacific, Latin America, the Middle East, and Africa, which was broader than 2024.
The capital picture is much more concentrated. In 2024, North America captured 53.9% of capital. In 2025, North America and Europe together captured about 75.2% of capital. So far in 2026, North America and Europe together capture about 97.3% of capital.
The 2026 deal-count picture also shows concentration, but in a different direction. Europe accounts for 63.0% of deals, while North America accounts for 25.9%. Asia-Pacific, the Middle East, Latin America, and Africa together account for only a small share of disclosed activity so far.
The honest interpretation is that AgriTech entrepreneurship is more global than AgriTech scale financing. Startups can emerge across many regions, but large disclosed equity rounds still cluster heavily in North America and Europe.
For a fuller regional view across North America, Europe, Asia-Pacific, Latin America, the Middle East, and Africa, see the market report covering AgriTech regional funding.
This chart, featured in our AgriTech market deck, shows how precision farming tools have driven growth in the AgriTech market over time
Is AgriTech capital moving toward proven winners or new opportunities?
AgriTech capital is moving decisively toward proven winners, even though new opportunities are receiving more small checks. Follow-on rounds represented 81.2% of deals and 97.2% of capital in 2024, 82.9% of deals and 96.1% of capital in 2025, and 63.0% of deals and 90.6% of capital so far in 2026.
That pattern is extremely clear. The AgriTech market is open to new entrants, but almost all meaningful capital still goes to companies that have already raised before, shown technical proof, built deployment experience, or established a stronger commercial path.
The 2026 year-to-date period is especially useful because it shows both sides of the market at once. First financings are 37.0% of deals, which means new opportunities are visible. But those first financings capture only 9.4% of capital, which means investors are keeping new-company exposure limited.
The better interpretation is a two-speed funding structure. New AgriTech companies can raise enough to test feasibility, but proven companies absorb the scale capital. Halter, Innovafeed, Miraterra, 701x, Kilter, Resurrect Bio, Rainbow Crops, and other follow-on companies show how much capital favors prior validation.
This is not a market where novelty alone is enough. The biggest checks go to farm-gate technologies that have moved beyond a lab, concept, or pilot and can show a route to measurable farmer or strategic-buyer value.
Is the AgriTech market becoming winner-takes-most?
Yes, the AgriTech market is becoming winner-takes-most in capital allocation, but not in company formation. The clearest current evidence is that the largest YTD 2026 deal captured 50.7% of all disclosed capital, while the top three deals captured 68.5% and the bottom half of deals captured only 8.3%.
Concentration was already a major feature of the market before 2026. In 2024, the top three deals captured 46.0% of capital and the top five captured 56.8%. In 2025, the top three captured 40.9% and the top five captured 52.7%.
The difference in 2026 is the extremity of the largest round. The largest YTD 2026 deal is 31.4 times the median round size, compared with 13.9 times in 2024 and 14.4 times in 2025. The gap between the leading company and the typical funded company has widened sharply.
At the same time, 27 companies or company-level financing events have still appeared so far in 2026. The market is not winner-takes-all because many companies can still raise. It is winner-takes-most because the companies with the strongest proof absorb a disproportionate share of dollars.
The practical reading rule is to separate funding breadth from funding power. Deal count shows how many companies are alive; top-round concentration shows where investors actually have conviction.
Is the next wave of AgriTech winners becoming visible?
Yes, the next wave of AgriTech winners is becoming visible, but the strongest signals are emerging at the subtheme level rather than being settled company by company. The clearest winning zones are virtual fencing and livestock productivity, biological crop protection, AI-enabled crop traits, autonomous weeding, precision spraying, soil intelligence, pollination measurement, and input-reduction technologies.
Livestock technology is the most obvious current scale theme. Halter’s $220M round, Innovafeed’s $59.7M round, 701x’s $10M round, and earlier activity around Nofence, Agteria, Number 8 Bio, and Ruminant BioTech show that livestock productivity, animal monitoring, feed inputs, and emissions reduction have become investable farm-economics categories.
Biologicals show the clearest next-wave pipeline by number of companies. Repeated financing across companies such as Inari, Vestaron, Micropep, AgroSpheres, SOLASTA Bio, Resurrect Bio, Rainbow Crops, SenseUP, Bindbridge, Agriodor, and Biographica points to durable interest in crop-input substitution, trait innovation, and biological discovery platforms.
Robotics winners are becoming visible where the task is narrow, repetitive, and expensive. Weeding, spraying, greenhouse harvesting, mushroom harvesting, UV-C treatment, orchard intelligence, and tractor autonomy are more credible than broad general-purpose farm robot claims.
The next wave is not simply “more AgriTech.” The stronger winners are likely to combine field proof, direct ROI, strategic channel access, and repeatability across crops, animals, farms, or geographies.
As this chart shows, and as featured in our AgriTech market deck, search interest in indoor farming has been growing steadily
Is the AgriTech funding landscape fragmenting or consolidating?
The AgriTech funding landscape is fragmenting by number of companies and technical approaches, but consolidating by capital allocation. Deal count increased from 32 in 2024 to 41 in 2025, and 2026 already has 27 disclosed deals through early July.
The fragmentation is visible across subcategories. Agricultural Biologicals are splitting into RNAi, fungal biocontrol, crop immunity, gene editing, crop traits, biofertility, biostimulants, peptide bioinsecticides, and microbial inputs. Automation is splitting across tractors, weeding, greenhouse harvesting, precision spraying, pollination, and field robotics.
But the capital pool is consolidating around a small number of scaled winners. In 2025, the top 10 deals captured 68.6% of capital. So far in 2026, the top 10 deals capture 85.0% of capital.
The best description is fragmented experimentation and consolidated conviction. Many companies are being funded, many technical paths are being tested, but only a small number of companies are crossing into large institutional financing.
For more detail on how AgriTech funding is splitting by subcategory, stage, geography, and concentration, see the full market view on AgriTech funding structure.
Where is investor attention shifting in the AgriTech market?
Investor attention in the AgriTech market is shifting toward farm-gate technologies with measurable operating impact: livestock productivity, biological crop protection, crop trait acceleration, automation, sensing, and precision input reduction. The strongest current signals are Animal Health Technologies leading YTD 2026 capital and Agricultural Biologicals leading YTD 2026 deal count.
The shift away from standalone software is just as important. Farm Management Software went from five deals in 2024 to one deal in 2025 and zero deals so far in 2026. Investors are not abandoning data or AI; they are demanding that data and AI attach to sensors, collars, sprayers, robotics, genetics, soil measurement, or input development.
Investor attention is also shifting toward technologies with strategic relevance. Biologicals deals repeatedly involve agriculture specialists and strategics such as Corteva Catalyst, Bayer-linked capital, Syngenta, FMC, AgFunder, Capagro, and sector-focused funds. Robotics and automation rounds increasingly involve equipment, climate, and agriculture specialists such as Kubota, Nufarm, Pymwymic, and other domain investors.
The strongest reading is that investors are rewarding technologies that prove one of four things: lower labor cost, lower chemical or fertilizer use, improved animal productivity, or higher crop resilience. Generic digital-transformation narratives no longer carry enough weight without a direct farm-economics link.
The AgriTech market is therefore becoming more practical and less narrative-driven. The winning investor questions are no longer “Is this an exciting agricultural technology?” but “Does this change farm economics, can it scale outside one niche, and do strategic players care enough to help commercialize it?”
INSIGHTS
The insights below come from reviewing disclosed equity rounds in the AgriTech market between January 2024 and July 2026, with special attention to category mix, stage mix, geography, concentration, investor repetition, and the difference between headline funding and typical company financing.
- The AgriTech market’s headline capital trend understates how selective the market has become. Full-year funding fell from about $1.02B in 2024 to about $853M in 2025, while deal count rose from 32 to 41, meaning more companies were financed but with smaller average checks.
- The 2026 year-to-date funding increase is not a broad-market rebound. Disclosed capital is about 5% higher than over the comparable 2025 period, but Halter alone accounts for about 51% of YTD 2026 capital, so the ordinary funding base is weaker than the headline implies.
- Median round size is the best single indicator of ordinary AgriTech market conditions. The median round fell from $16.8M in 2024 to $10M in 2025 and $7M so far in 2026, while headline totals remain distorted by large rounds.
- The AgriTech market has a widening gap between innovation breadth and capital conviction. YTD 2026 has 27 deals across six months, but the bottom half of deals accounts for only about 8% of capital.
- Animal Health Technologies is the clearest capital-conviction category, not the broadest innovation category. The category has only 14.8% of YTD 2026 deals but 67.5% of capital, showing that livestock productivity and animal systems can command large checks once proof exists.
- Agricultural Biologicals is the clearest experimentation category. The category has 48.1% of YTD 2026 deals but only 17.6% of capital, which means investors are funding many shots on goal without yet underwriting most of them as scaled winners.
- Farm Automation Systems remains structurally important but less euphoric than in 2025. Automation led full-year 2025 with 41.5% of deals and 39.7% of capital, but so far in 2026 it has 18.5% of deals and only 8.3% of capital.
- Standalone Farm Management Software has lost investor priority. The category fell from five deals in 2024 to one in 2025 and zero so far in 2026, indicating that investors now prefer software embedded in physical or biological systems.
- Precision Agriculture Tools are not dead, but they are no longer funded as a broad horizontal category. Investor interest appears strongest when precision tools are tied to specific input reduction, crop monitoring, or plant-by-plant intervention.
- The AgriTech market is increasingly a proof market rather than a promise market. Large rounds cluster around companies with deployment, production assets, customer traction, strategic validation, or direct farm-level ROI.
- First financings are recovering by count but not by dollars. So far in 2026, first financings are 37.0% of deals but only 9.4% of capital, showing that investors are testing new opportunities cautiously.
- The AgriTech market is more barbell-shaped in 2026 than in prior years. There are 12 deals below $5M, 13 deals between $5M and $20M, no deals between $20M and $50M, and two deals above $50M.
- The missing $20M to $50M middle in 2026 is a warning sign. It suggests many companies can raise validation rounds, but few are reaching the institutional scale-up zone between early commercialization and major growth rounds.
- Europe is the most important region for deal formation. Europe accounts for 63.0% of YTD 2026 deals, up from 39.0% in 2025 and 15.6% in 2024.
- North America remains the most important region for scale capital. North America accounts for 59.3% of YTD 2026 capital despite only 25.9% of deals, largely because the region captured the largest round.
- Europe’s lower median round size implies more experimentation than scale dominance. Europe has many funded companies, but North America still produces larger financing outcomes.
- Asia-Pacific’s apparent loss of momentum in 2026 is partly an outlier problem. The region’s 2024 and 2025 capital shares were helped by large Scigene and Halter rounds, so the 2026 drop does not necessarily prove a broad regional decline.
- Strategic investors are more important in AgriTech than in many software markets. Corteva, Kubota, Capagro, AgFunder, Pymwymic, Nufarm, and similar sector specialists provide technical, channel, and credibility signals that generalist VC alone cannot provide.
- Biologicals funding increasingly rewards platform optionality rather than single-product novelty. The stronger biologicals stories involve repeatable discovery engines, trait-development platforms, RNAi, gene editing, crop immunity, or crop-protection pipelines.
- Livestock technology has become a high-conviction climate-and-productivity category. Virtual fencing, cattle monitoring, feed inputs, methane reduction, and animal productivity technologies are attracting capital because they connect sustainability to immediate farm economics.
- Robotics funding is strongest when the task is narrow, repeated, and expensive. Weeding, spraying, greenhouse harvesting, mushroom harvesting, UV-C treatment, and tractor autonomy are more credible than broad claims of general farm automation.
- The next wave of AgriTech winners is likely to come from companies that combine field proof, strategic validation, and measurable farm ROI. The companies least likely to command scale capital are those relying only on generic software claims, broad sustainability language, or undifferentiated sensing without a clear economic payoff.
This chart, featured in our AgriTech market deck, shows how smart irrigation system technology has evolved over time
OUR METHODOLOGY TO BUILD THIS TRACKER
We built this AgriTech funding tracker by reviewing publicly disclosed equity rounds raised by pure-play AgriTech companies between January 2024 and July 2026. A company counts as pure-play when more than 80% of its activity is dedicated to technologies that improve agricultural production and input performance up to the farm gate.
The market definition includes on-farm hardware, software, sensors, automation, farm management systems, decision-support tools, agricultural input innovation, seeds, crop traits, crop protection, biologicals, fertilizers, animal health, animal productivity, and feed technologies. The definition excludes downstream food processing, food retail, consumer food apps, generic logistics, generic fintech, and enterprise software unless the product is specifically designed for agricultural production use cases.
We applied four core filters. First, we only included equity rounds, so grants, debt-only financings, structured financings, acquisitions, and non-equity transactions are excluded. Second, we only counted rounds of $300K or more. Third, we only kept pure-play companies under the 80% rule. Fourth, every entry had to be confirmed by a direct company announcement, press release, tier-1 media report, specialized industry source, investor announcement, or credible regional publication.
Undisclosed-amount rounds are excluded because including them would distort dollar-based metrics such as total capital, average round size, category share, regional share, and concentration ratios. Deals with disclosed amounts are kept even when the stage is Unknown, because the capital amount can still be used reliably in the market calculations.
The final evidence base covers full-year 2024, full-year 2025, and year-to-date 2026 through early July. Every average, median, share, concentration metric, stage split, geography split, and first-financing calculation is based on the disclosed sample that passed the filters above. Privately raised rounds that were never publicly announced are necessarily missing, which is a known limitation of any public-only AgriTech funding tracker.
Related blog posts
- What is new in the AgriTech market?
- The latest news in the AgriTech market
- What is the real size of the AgriTech market?
- The latest funding news in the AgriTech market
- How funding activity has evolved in the AgriTech market
- The startups that have raised the most funding in the AgriTech market
